PYPD · Polypid Ltd
United States · RS rating 90 · As of 2026-11-03
| Price | 5.46 USD |
|---|---|
| 1-day change | +0.7% |
| RS rating (overall / 1M / 3M / 12M) | 90 / 72 / 89 / 82 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 47 / 74 / 50 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -10.8% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +5.5% |
| Market cap (USD) | $88.5M |